...A. Note: Miroslava Minkova's last earnings call. 1. B. Results: Another excellent qtr. with sustained momentum in bookings, revenues, margin improvement and EPS growth. 1. Teams continued to innovate and execute well, managing through well-publicized supply chain challenges. a. b. Confident that Co. is now well on track for excellent financial and operational progress in 2021. 2. Revenues increased 19.1% YoverY to $609m. Organic revenues increased 17.8% YoverY, which included 16.8% organic growth in Bruker Scientific Instruments Groups and 29.3% at BEST, net of intercompany eliminations. a. 3. Non-GAAP GM expanded 210 BP YoverY to 51.7%. 4. Non-GAAP operating margin, 20.6%. Improved 200 BP over 18.6% in 3Q20. a. 5. GAAP diluted EPS $0.57 vs. $0.35 reported in 3Q20. 6. Non-GAAP diluted EPS, $0.63. Up 50% from $0.42 in 3Q20. a. b. 3Q21 included tax benefit of approx. $0.06 on certain discrete items. 7. Excellent 3Q with strong revenue growth, operating leverage and favorable tax performance...